Ailments have certain corollaries that can’t be avoided. Loss of hunger or appetite is one among them. Not only is this consequential to multiple diseases and illnesses, it is also one of the most pernicious as it can incapacitate a patient to exponential levels of feebleness, sometimes even causing fatality (specific of cancer patients). TSRI […]
Up until now, photodynamic therapies have heavily relied on the content of O2 prevalent within the tissue. This, however, is rendered useless in the case of malignant and burgeoning tumours. Thus, a research team from Karlsruher Institut Fur Technologie (KIT) situated in Keiv, has contrived a photoswitchable molecule in order to supplement the method of […]
Drug delivery companies and the products borne from them are often characterised by complex partnerships between companies, with licensing agreements and strategic relationships. The challenges they seek to face and overcome rely upon strong technology delivering drugs to targeted sites in the patient. Outsourcing of opportunities has dramatically increased over the last decade. As a […]
Traditional way of drug making has extensively outdated. While many manufacturers have adapted efficient methods in manufacturing, but still a sizeable pharmaceutical companies work on an outmoded approach that is highly lethargic, inflexible, and prone to frequent breakdowns. A new invention of refrigerator-sized apparatus that can intake a set of ingredients and quickly able to produce four […]
Powder Systems Limited “Powder Systems Limited (PSL) has been exporting its technology to the Asia-Pacific market since 1990 and a growing number of turn-key installations are to be commissioned in this region in the future. To support the demand, PSL has committed to further investment in Asia-Pacific (APAC) by opening an engineering and sales office […]
Condition: Medicated for patients suffering from Obesity. Effectiveness: ★★★ Ease of Use: ★★★★ Satisfactory Index: ★★ Weight-loss drug Belviq also known as lorcaserin HCI has been popular in the market because it’s known to help reducing obesity amongst adults. During the clinical trials, however, side effects like headache, upper respiratory tract infection, nasopharyngitis, sinusitis and […]
Condition: Estrogen Receptor (ER)-Positive, HER2-Negative Postmenopausal Effectiveness: ★★★ Ease of Use: ★★★ Satisfactory Index: ★★★ Therapeautic drug, Ibrance (Chemical name: Palbociclib), recently approved by the U.S. Food and Drug Administration in February 2015, is intended to be paired with the hormonal therapy medicine Femara (Chemical name: Letrozole) as a comprehensive treatment for locally advanced-stage or metastatic, hormone-receptor-positive, HER2-negative […]
The historical approach to clinical drug development, and one that served drug companies well for the past thirty years, was to initiate testing in humans at clinical research units, typically located in the UK and the US and to proceed further to Phase II testing and beyond to patients with clinical evidence of the disease […]
The incidence of Central Nervous System (CNS) illness is on the upswing and exacts a heavy human and economic toll. According to the World Health Organization, more than 120 million people worldwide suffer from depression, and the number is expected to rise. The occurrence of Alzheimer’s disease is slated to grow by more than 100 […]
Over the past decade there has been increasing pressure on the pharmaceutical industry to increase economic efficiencies in drug discovery. This has been driven by several factors including the increased costs of R&D, lower productivity, patent expiration, generic competition and the increasing difficulty in bringing new chemical entities to market. The extraordinary investment requirements have […]